Connect with us


Are There Side Effects of CBD



With a series of discoveries, the public mind has begun to focus on the remarkable possibilities for health and well-being that have come from research and exploration into the properties of Cannabidiol (CBD). But, as with all such processes, people also want to know if there are unwanted side effects to harnessing these positives.

We will try to answer that question thoroughly in the piece that follows.

Uncertainty, Disinformation, and CBD

There’s no way to escape the public relations problem that anything has inherently if it comes from something culturally associated with what has been an illegal drug for most of the last 50 years. CBD comes from the cannabis plant. So, naturally, people are concerned that it may ultimately be bad for them.

But that’s why we like to spread the balm of truth all over that issue; to heal it with facts.

First off, CBD has been shown to potentially slow the development of malignant cancer cells. It may be useful in treating potential disorders in cancer cell relocation, tumor neoplasms, and metastasis that permit the proliferation of cancer in the body.

This type of impact can be intimidating to big pharma. Some large market drugs can cost as much as $400 million to develop. Hence, there may at times be at least a slight incentive for the spread of misinformation about CBD.

We already have sound anecdotal evidence suggesting that CBD can aid in the treatment of many health complications, including:

  • alcohol and opiate abuse,
  • Alzheimer’s disease,
  • asthma,
  • arthritis,
  • diabetes mellitus,
  • epilepsy,
  • leukemia,
  • migraine,
  • nausea,
  • vomiting, and
  • pain relief in spinal cord injuries

There is much work yet to be done. And research has not proven CBD as a standalone treatment for any of these conditions. You should not believe that the “medical establishment” is out to get you. And you should trust that your doctor provided he or she is a licensed physician with genuine and accredited medical training.

But, nonetheless, we want to clear up misconceptions about side effects for CBD that could stifle the mainstream development of this healthy movement before it really gets off the ground.

CBD Oil and Side Effects

While the overwhelming and vast majority of genuine effects derived from CBD consumption are highly positive, there are a few unwanted side effects that can under, but they are exceedingly rare and only arise under very specific and uncommon conditions.

The big point is this: if you only consume high-quality CBD from reputable sources, you will almost certainly never deal with any unwanted side effects.

In addition, the cases in which people find themselves subject to unwanted effects from CBD almost always arise under conditions associated with other extreme health problems.

Here are some of the most common side effects from CBD usage:

  • Dry mouth can occasionally occur through use of CBD
  • Parkinson’s Patients may experience heightened tremors from very high doses of CBD
  • Some Pharmaceuticals don’t mix well with CBD because of its effect on certain liver enzymes that metabolize some drugs
  • Lightheadedness can happen at higher CDB dosages
  • CBD can lower blood pressure briefly upon initial active usage (consult doctor before taking CBD if you take blood pressure medication)
  • Drowsiness is rare but can occur with CBD usage at high doses

However, as noted above, these are still not typical experiences and all of them are temporary. And the benefits massively outweigh this list of relatively minor inconveniences for those who do experience them.

Finally, the CBD user is in control: all of these elements of the experience can be controlled by adjusting dosage levels.

CBD Oil Quality Level and Side Effects

Likewise, you need to make your main priority that the quality of your CBD oil additionally is as immaculate as possible. This removes the remaining uncertainty and ensures an experience free from unwanted effects.

Accordingly, you should do sufficient research given that these plants can assimilate substantial metals from the soil where they were developed. It’s always a good idea to understand precisely what you are putting into your body.

We would also suggest that, if uncertain, you take the step of demanding a third-party lab test before purchasing and consuming CBD oil products from an unknown supplier.

CBD, Side Effects, and Concluding Remarks

As discussed above, cannabinoids are divided into two groups. Endocannabinoids are produced naturally in the human body, while Phyto-cannabinoids are found in many plants, with cannabis being one of the most prominent.

One such phyto-cannabinoid is Cannabidiol (CBD). In this case, it has been shown to be effective in treating many conditions with only mild and uncommon side effects that can be controlled through proper dosage and reliance on high-quality standards.

CBD has been shown to help joint pain, diabetes, liquor addiction, Multiple Sclerosis, chronic pain, schizophrenia, PTSD, antibiotic-safe contaminations, epilepsy, and other neurological disorders.

CBD is for individuals who swear by cannabis, who would prefer not to miss the mending properties of the plant, but aren’t looking for the “high” that comes with high-THC strains.

By practicing an allegiance to high quality standards and scaling dosage properly, most if not all potential side effects should be easily avoided.


CannTrust Holdings Inc (NYSE:CTST) Penetrates Into The United States After Investing $20 Million



CannTrust Holdings Inc (NYSE:CTST), a Canadian company that produces and sells medical and recreational marijuana has announced the expansion of its business into the United States.

The Canadian firm revealed that it signed a Letter of Intent through which it will start working with Elk Grove Farming Company, LLC to access more than 3,000 hemp production acres in California. The two companies struck a joint partnership that will allow CannTrust to secure a footing in the California market which is one of the biggest cannabis markets in the U.S.

“This agreement represents another bold move for CannTrust. Our U.S. operation is expected to deliver a significant increase in low-cost production capacity,” stated CannTrust CEO Peter Aceto.

CannTrust is financially ready to tap into the U.S market

The CannTrust CEO also noted that the company will take advantage of its experience in the formulation of standardized CBD products as part of its strategy to enter the U.S market. Mr. Aceto also revealed that his company’s successful equity offering provided enough financial muscle to fuel its ambitious expansion plans.

CannTrust aims to be among the leading and trusted suppliers of high-quality, standardized CBD formulations derived from hemp. The company believes that there will be an increasing demand for high-grade CBD formulations from international retailers. It therefore makes sense to invest in processes that will add value to the end product such as genetic studies and expert growing practices to achieve the highest safety and quality standards.

Elk Grove and CannTrust will each have 50% ownership in their joint operations. Elk Grove is an ideal partner for the endeavor because it has years of farming experience in a variety of products. Its focus includes products designed for crop protection, supply, and input. Its operations are distributed across California, which means that the groundwork has already been laid for the partnership. It will thus be easier for the CannTrust to penetrate into the California market.

Elk Grove executive Morgan Houchin stated that his company was excited about the partnership with CannTrust. He added that his firm’s experience in farming operations will be a great combination with CannTrust’s experience in creating class-leading formulations.

Continue Reading


Rocky Mountain High Brands Inc (OTCMKTS:RMHB) Strikes Broker Deal With Carlin Group



Lifestyle brand management firm Rocky Mountain High Brands Inc (OTCMKTS:RMHB) announced on Wednesday that it secured a broker deal with Carlin Group for its products in the retail space.

The broker agreement will allow Carlin to represent RMHB’s CBD-infused drinks through the HEMPd brand. It will also represent beverages infused with Hempseed extract under RMHB brands. The deal will also cover CBD-infused wellness products such as lotions, water-soluble solutions, capsules, gummies and tinctures as part of the HEMPd brand. Spirit Water will also be covered under the agreement.

The RMHB-Carlin broker deal covers multiple states. They include Missouri, Nebraska, Texas, South Dakota, North Dakota, Minnesota, Wisconsin, Illinois, Pennsylvania, Tennessee, Kentucky, Ohio, Indiana, and Michigan.

“We are very excited about the opportunity to have our entire product line represented by Carlin Group,” stated RMHB CEO Michael Welch.

The Carlin broker deal will boost RMHB’s exposure

Welch noted that the broker deal will strategically allow RMHB to leverage optimal exposure to mass marketers, grocery store chains, convenient stores, major retailers and other types of outlets. The company would not have managed to reach such a wide range of outlets cost-effectively without a broker deal.

The RMHB CEO also added that his company and Carlin will maintain a close collaboration so that they can facilitate retail availability of RMHB products. Welch also revealed that RMHB reviewed numerous other retail introduction options. This was before settling on Carlin which the company believes is the best-suited brand to rapidly get its products onto retail shelves.

Carlin Group’s Managing Director Albert Vergilio noted in a statement that his company was excited to host RMHB and the CBD-based products that are part of its HEMPd brand in Carlin’s new CBD division. He also added that it is part of investing in the future of CBD considering the fast-tracked popularity of CBD products, and the regulations that govern them.

Carlin’s sales team will undergo some training to get them acquainted with RMBH’s products. The sales team will then hold meetings with corporate customers as part of the retail rollout of the products. Sales that will be part of the broker deal are expected to kick off in Q3.

Continue Reading


Wildflower Brands Inc (OTCMKTS:WLDFF) Establishes Footprint Across The US With PO For Hemp CBD Products From Dillard’s Department Stores And Eyes Markets In Texas And Florida



Wildflower Brands Inc (OTCMKTS:WLDFF) has announced establishing a nationwide presence with a PO from Dillard’s Department store. The company has fulfilled the PO received from Dillard.

Hemp CBD products in 292 locations

Dillard’s department store will showcase the premium hemp CBD products of Wildflower in its 292 locations across the US. With its best practices and transparency, Wildflower is eyeing the key markets in Texas and Florida. The company will educate the customers in these regions about salable products. Wildflower has received subsequent orders from Dillard’s and is fulfilling the requirements.

Chief Executive Officer of Wildflower, William Maclean said the supply of CBD infused products to Dillard’s Department stores doubles the existing retail locations in the nation. The company aims to capitalize on its brand to become a household name. It will improve loyalty building because of the reputation and respect of Dillard’s as a retailer. Wildflower aims to provide health and wellness benefits of its CBD infused products to the customers in the US through Dillard’s.

Signs a deal with Highmark Interactive

Wildflower has signed a deal to use EQ – Brain Tracking, mobile software of Highmark Interactive, in the clinical research to study the functional neurological and cognitive effects of CBD. The company aims to get meaningful results and data that help to understand the functional and cognitive neurological properties of the cannabinoids.

William said the company would collect testimonials from the customers on its products that provide the health and wellness needs using plant-based solutions. The company will strive to improve the products, and the research helps it to reach that goal and growth with continued investments.

Acquires City Cannabis Corp

Wildflower has signed an LOI on April 3, 2019, to take over City Cannabis Corp. The company will issue its 60 million common shares for the takeover. The companies will complete the acquisition on receiving advice from corporate, tax, and securities law departments.

The cannabis retailer City Cannabis holds two licenses in the City of Vancouver to market cannabis. It is generating profits through operating dispensaries in Vancouver. The acquisition helps Wildflower to expand retail footprint using the expertise of City Cannabis.

Continue Reading

Trending Stories